For the Inventor, By the Inventor

Enter assignee name

Dallas, TX, United States of America

Baylor Research Institute

USPTO Granted Patents = 96

% Expired Patents = 18.8

CIPO Patents = 7

EPO Patents = 36

Forward Citations = 727

Loading Chart...

Loading Chart...

88 inventors (with patents filed for the assignee):

Jacques F Banchereau (42 out of 47 patents)

Gerard Zurawski (38 out of 52 patents)

Sandra M Zurawski (33 out of 40 patents)

4. SangKon Oh (29 out of 29 patents)

5. Anne-Laure Flamar (17 out of 17 patents)

6. Yves Levy (10 out of 19 patents)

7. Ajay Goel (9 out of 10 patents)

8. Charles R Roe (9 out of 11 patents)

9. Dapeng Li (9 out of 10 patents)

10. Anna Karolina Palucka (7 out of 7 patents)

11. Eynav Klechevsky (7 out of 9 patents)

12. Monica Montes (6 out of 6 patents)

13. C Richard Boland (6 out of 6 patents)

14. Virginia Pascual (6 out of 6 patents)

15. Maria Virginia Pascual (5 out of 5 patents)

Core Competencies:

Immunotherapy

Anti-CD40 Antibodies

Dendritic Cell Vaccines

HPV Vaccines

Cancer Antigens

HIV Treatment

Colorectal Cancer

Autoimmune Conditions

Biomarkers

Fusion Proteins

Antigen-Presenting Cells

Inflammatory Conditions

96 patents: Sort by Forward Citations

1. 12714745 - AGENTS THAT ENGAGE ANTIGEN-PRESENTING CELLS THROUGH DENDRITIC CELL ASIALOGLYCOPROTEIN RECEPTOR (DC-ASGPR) (2026-08-25),

2. 12576147 - RECOMBINANT PROTEINS WITH CD40 ACTIVATING PROPERTIES (2026-03-17),

3. 12214034 - Vaccines against HPV and HPV-related diseases (2025-02-04),

4. 12186379 - Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosis (2025-01-07),

5. 12016915 - Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) (2024-06-25),

6. 11957734 - Methods and compositions for treating autoimmune and inflammatory conditions (2024-04-16),

7. 11806390 - Fusion proteins comprising an anti-CD40 antibody and cancer antigens (2023-11-07),

8. 11717567 - Vaccines against HPV and HPV-related diseases (2023-08-08),

9. 11666286 - Classification of polyps using learned image analysis (2023-06-06),

10. 11618926 - Methods for diagnosing, prognosing, and treating colorectal cancer using biomarker expression (2023-04-04),

11. 11571365 - Intraluminal tubes with deployable structures and related methods (2023-02-07),

12. 11406688 - Compositions and methods for the systemic treatment of arthritis (2022-08-09),

13. 11267895 - Nucleic acids encoding anti-CD40 antibodies (2022-03-08),

14. 11219683 - Methods and compositions for treating and preventing HIV (2022-01-11),

15. 11173202 - Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) (2021-11-16),

Company Overview

Baylor Research Institute, located in Dallas, Texas, is at the forefront of immunotherapy research, focusing on innovative treatments for various diseases. The institute specializes in developing therapies involving anti-CD40 antibodies, dendritic cell vaccines, and HPV vaccines, targeting conditions such as colorectal cancer and autoimmune disorders. With a commitment to advancing medical science, Baylor Research Institute aims to improve patient outcomes through groundbreaking research and clinical trials in the field of immunotherapy.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

96 Patents

#22 in Dallas, TX

#215 in Texas

#3,921 in US

#8,063 in the World

Dallas, TX, United States of America

Baylor Research Institute

Forward Citations = 727

88 inventors:

Jacques F Banchereau (42 out of 47 patents)

Gerard Zurawski (38 out of 52 patents)

Sandra M Zurawski (33 out of 40 patents)

4. SangKon Oh (29 out of 29 patents)

5. Anne-Laure Flamar (17 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Baylor Research Institute. Retrieved from https://idiyas.com/company/baylor-research-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…